Apolipoprotein e genotype, dementia, and mortality in the oldest old: The 90+ Study

Alzheimer's and Dementia

Volumn 9, Issue 1, 2013, Pages 12-18

  Corrada, María M ^a,b   Paganini Hill, Annlia ^a,c   Berlau, Daniel J ^d   Kawas, Claudia H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d REGIS UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia; Mortality; Oldest old

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E4;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; UNITED STATES; VERY ELDERLY;

AGED, 80 AND OVER; APOLIPOPROTEIN E4; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MORTALITY; RISK FACTORS;

EID: 84872101594     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.12.004     Document Type: Article

References (42)

1. L.A. Farrer, L.A. Cupples, J.L. Haines, B. Hyman, W.A. Kukull, and R. Mayeux Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium JAMA 278 1997 1349 1356
2. O.Y. Bang, Y.T. Kwak, I.S. Joo, and K. Huh Important link between dementia subtype and apolipoprotein E: a meta-analysis Yonsei Med J 44 2003 401 413
3. M. Ganguli, V. Chandra, M.I. Kamboh, J.M. Johnston, H.H. Dodge, and B.K. Thelma Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia Study Arch Neurol 57 2000 824 830
4. A.G. Yip, C. Brayne, D. Easton, and D.C. Rubinsztein Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population J Med Genet 39 2002 639 643
5. G.W. Rebeck, T.T. Perls, H.L. West, P. Sodhi, L.A. Lipsitz, and B.T. Hyman Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals Neurology 44 1994 1513 1516
6. E. Sobel, J. Louhija, R. Sulkava, Z. Davanipour, K. Kontula, and H. Miettinen Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians Neurology 45 1995 903 907
7. R. Sulkava, K. Kainulainen, A. Verkkoniemi, L. Niinisto, E. Sobel, and Z. Davanipour APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+ Neurobiol Aging 17 1996 373 376
8. R. Gessner, F.M. Reischies, A. Kage, B. Geiselmann, M. Borchelt, and E. Steinhagen-Thiessen In an epidemiological sample the apolipoprotein E4 allele is associated to dementia and loss of memory function only in the very old Neurosci Lett 222 1997 29 32
9. I. Skoog, C. Hesse, O. Aevarsson, S. Landahl, J. Wahlstrom, and P. Fredman A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality J Neurol Neurosurg Psychiatry 64 1998 37 43
10. K. Juva, A. Verkkoniemi, P. Viramo, T. Polvikoski, K. Kainulainen, and K. Kontula Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over Int Psychogeriatr 12 2000 379 387
11. K. Juva, A. Verkkoniemi, P. Viramo, T. Polvikoski, K. Kainulainen, and K. Kontula APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old Neurology 54 2000 412 415
12. C. Qiu, M. Kivipelto, H. Aguero-Torres, B. Winblad, and L. Fratiglioni Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex J Neurol Neurosurg Psychiatry 75 2004 828 833
13. E.H. Corder, L. Lannfelt, and H. Basun Apolipoprotein E genotype and the rate of decline in probable Alzheimer's disease Arch Neurol 53 1996 1094 1095
14. R.S. Tilvis, T.E. Strandberg, and K. Juva Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample J Am Geriatr Soc 46 1998 712 715
15. L. Bathum, L. Christiansen, B. Jeune, J. Vaupel, M. McGue, and K. Christensen Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians J Am Geriatr Soc 54 2006 654 658
16. D.J. Berlau, M.M. Corrada, E. Head, and C.H. Kawas APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old Neurology 72 2009 829 834
17. M.M. Corrada, R. Brookmeyer, A. Paganini-Hill, D. Berlau, and C.H. Kawas Dementia incidence continues to increase with age in the oldest-old: The 90+ Study Ann Neurol 67 2010 114 121
18. Corrada MM, Berlau DJ, Kawas CH. A population-based clinicopathological study in the oldest-old: The 90+ Study. Curr Alzheimer Res (in press).
19. C. Whittle, M.M. Corrada, M. Dick, R. Ziegler, K. Kahle-Wrobleski, and A. Paganini-Hill Neuropsychological data in nondemented oldest-old: The 90+ Study J Clin Exp Neuropsychol 29 2007 290 299
20. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
21. E.L. Teng, K. Hasegawa, A. Homma, Y. Imai, E. Larson, and A. Graves The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia Int Psychogeriatr 6 1994 45 58
22. J.M. Silverman, R.S. Keefe, R.C. Mohs, and K.L. Davis A study of the reliability of the family history method in genetic studies of Alzheimer's disease Alzheimer Dis Assoc Disord 3 1989 218 223
23. C.H. Kawas, J. Segal, W.F. Stewart, M.M. Corrada, and L.J. Thal A validation study of the dementia questionnaire Arch Neurol 51 1994 901 906
24. C.M. Clark, and D.C. Ewbank Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease Alzheimer Dis Assoc Disord 10 1996 31 39
25. S. Katz, A.B. Ford, R.W. Moskowitz, B.A. Jackson, and M.W. Jaffe Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function JAMA 185 1963 914 919
26. R.I. Pfeffer, T.T. Kurosaki, C.H. Harrah, J.M. Chance, and S. Filos Measurement of functional activities in older adults in the community J Gerontol 37 1982 323 329
27. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Association Washington, DC
28. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944
29. K. Kahle-Wrobleski, M.M. Corrada, B. Li, and C.H. Kawas Sensitivity and specificity of the mini-mental state examination for identifying dementia in the oldest-old: The 90+ Study J Am Geriatr Soc 55 2007 284 289
30. M.M. Corrada, R. Brookmeyer, D. Berlau, A. Paganini-Hill, and C.H. Kawas Prevalence of dementia after age 90: results from The 90+ Study Neurology 71 2008 337 343
31. Y. Zabar, and C.H. Kawas Epidemiology and clinical genetics of Alzheimer's disease C.M. Clark, J.Q. Trojanowski, Neurodegenerative Dementias. Clinical Features and Pathological Mechanisms 2000 McGraw-Hill New York, NY 79 94
32. J. Louhija, H.E. Miettinen, K. Kontula, M.J. Tikkanen, T.A. Miettinen, and R.S. Tilvis Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians Arterioscler Thromb 14 1994 1084 1089
33. F. Schachter, L. Faure-Delanef, F. Guenot, H. Rouger, P. Froguel, and L. Lesueur-Ginot Genetic associations with human longevity at the APOE and ACE loci Nat Genet 6 1994 29 32
34. K. Kervinen, M.J. Savolainen, J. Salokannel, A. Hynninen, J. Heikkinen, and C. Ehnholm Apolipoprotein E and B polymorphisms-longevity factors assessed in nonagenarians Arteriosclerosis 105 1994 89 95
35. I.M. Rea, I. Mc Dowell, D. McMaster, M. Smye, R. Stout, and A. Evans Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Free-living Ageing Study (BELFAST) Mech Ageing Dev 122 2001 1367 1372
36. R. Rontu, P. Ojala, A. Hervonen, S. Goebeler, P.J. Karhunen, and M. Nikkila Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians Clin Endocrinol (Oxf) 64 2006 265 270
37. G.J. McKay, G. Silvestri, U. Chakravarthy, S. Dasari, L.G. Fritsche, and B.H. Weber Variations in apolipoprotein e frequency with age in a pooled analysis of a large group of older people Am J Epidemiol 173 2011 1357 1364
38. P.K. Molsa, R.J. Marttila, and U.K. Rinne Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia Acta Neurol Scand 91 1995 159 164
39. A.M. Koivisto, P. Lempiainen, K. Koivisto, E.L. Helkala, L. Mykkanen, and J. Kuusisto Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study Neuroepidemiology 19 2000 327 332
40. G. Dal Forno, K.A. Carson, R. Brookmeyer, J. Troncoso, C.H. Kawas, and J. Brandt APOE genotype and survival in men and women with Alzheimer's disease Neurology 58 2002 1045 1050
41. C. Lahoz, E.J. Schaefer, L.A. Cupples, P.W. Wilson, D. Levy, and D. Osgood Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study Atherosclerosis 154 2001 529 537
42. E. Ghebremedhin, C. Schultz, D.R. Thal, U. Rub, T.G. Ohm, and E. Braak Gender and age modify the association between APOE and AD-related neuropathology Neurology 56 2001 1696 1701